general, page-12

More announcements that may be coming out shortly......?

1.The first US patient enrolment for Ovature is imminent. If they get mainstream media coverage showing the unique properties of PXD it could become quite a significant event.

2.First European hospital/patient enrolment..

3.The Yale Docetaxol/PXD combo study results..

4.Partnering progress? (perhaps a long shot at this stage)

Although Ovature is running way behind schedule the more liberal patient inclusion criteria may well compensate for some lost time in recruitment.